Park West Asset Management LLC - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 22 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Park West Asset Management LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2018$2,026,000
-24.4%
363,700
+24.2%
0.09%
-26.2%
Q4 2017$2,679,000
+4.5%
292,847
+4.4%
0.12%
-20.3%
Q3 2017$2,564,000
+101.3%
280,500
+36.5%
0.15%
+115.5%
Q2 2017$1,274,000
+26.8%
205,5000.0%0.07%
+20.3%
Q1 2017$1,005,000
+39.4%
205,5000.0%0.06%
+5.4%
Q4 2016$721,000
-20.9%
205,5000.0%0.06%
-32.5%
Q3 2016$912,000
-1.2%
205,5000.0%0.08%
-10.8%
Q2 2016$923,000
-8.9%
205,5000.0%0.09%
-2.1%
Q1 2016$1,013,000
-35.2%
205,5000.0%0.10%
-43.8%
Q4 2015$1,564,000
+2.4%
205,5000.0%0.17%
+21.6%
Q3 2015$1,527,000
-24.4%
205,500
+2.3%
0.14%
-26.1%
Q2 2015$2,020,000
+6.3%
200,788
-0.5%
0.19%
-32.1%
Q1 2015$1,901,000
+62.3%
201,8480.0%0.28%
+48.9%
Q4 2014$1,171,000
-32.5%
201,8480.0%0.19%
-27.6%
Q3 2014$1,736,000
-11.7%
201,8480.0%0.26%0.0%
Q2 2014$1,966,000
-14.3%
201,848
+0.9%
0.26%
-1.5%
Q1 2014$2,294,000200,0000.26%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q1 2015
NameSharesValueWeighting ↓
BVF INC/IL 1,832,484$13,469,0001.47%
Knoll Capital Management, LLC 206,099$1,515,0001.24%
683 Capital Management, LLC 1,350,000$9,923,0000.90%
Vivo Capital, LLC 971,337$7,139,0000.67%
P.A.W. CAPITAL CORP 70,000$515,0000.56%
Ibex Investors LLC 807,400$5,934,0000.48%
MEITAV INVESTMENT HOUSE LTD 639,269$4,693,0000.31%
Nantahala Capital Management 879,200$6,559,0000.20%
Rock Creek Group, LP 57,201$420,0000.19%
FIRST MIDWEST BANK TRUST DIVISION 164,847$1,212,0000.17%
View complete list of GALMED PHARMACEUTICALS LTD shareholders